Why shareholders should be rejecting the SMR takeover offer, page-7

First 7 Last

Share
Profile

Follow
KeithThomas

20 Posts.

08/02/19

14:36

Post #: 37377608
Share

Originally posted by nuadrehc: ↑

I wouldn’t be opposed to SMR taking out another listed coking coal producer in a script for script deal. As I mentioned previously given SMR’s size and assets as well as management’s growth aspirations SMR was always going to acquire another company to upgrade its portfolio rather than be taken out itself by another coal producer.

Issue with buying any privately-held asset or an asset level deal from another listed entity is that private markets are telling you that long-life coking coal assets are worth circa 4-6x EV/EBITDA whereas public markets are only valuing comparable assets at 2-3x. Thats why a script for script deal makes sense as if both of your shares are fundamentally undervalued by the market then script for script works for both parties.

Having said that the only listed producer that makes sense for SMR to buy is Bathurst Resources (BRL), which you can argue is even more undervalued by the market than SMR. A script for script offer at $0.15 makes obvious sense to both companies and I’m sure BRL shareholders would be running to swap their management team for Dan Clifford and Co. That deal would solve two things- massive dilution to Golden plus I could see the combined multi-asset $250m EBITDA entity rerating to a market cap of $1bn within 12 months of close. This is the most obvious win/win merger in the sector.

All my my own research and opinion. I hold both SMR and BRL. Do your own research.

Expand

Any scheme of arrangement or merger of Stanmore Coal will not succeed without the consent and support of Golden Investments which holds 25.5% stake, effectively a "blocking vote" ? No?

- KT

SMR Price at posting: $1.06 Sentiment: None Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

NOX

Noxopharm gets HERACLES autoimmune trials started with first human doses

LDX

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

LIS

Li-S Energy the latest microcap to pivot to US defence market

IMU

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.14		Change 0.030(1.42%)		Mkt cap ! $1.928B

Open	High	Low	Value	Volume
$2.11	$2.15	$2.07	$1.455M	685.6K

Buyers (Bids)

No.	Vol.	Price($)
29	20903	$2.13

Sellers (Offers)

Price($)	Vol.	No.
$2.14	38517	36

View Market Depth

No.	Vol.	Price($)
37	19928	2.140
21	24783	2.130
22	73092	2.120
17	84218	2.110
11	21965	2.100

Price($)	Vol.	No.
2.150	56025	43
2.160	43609	24
2.170	33566	15
2.180	82659	11
2.190	26332	5

Last trade - 12.54pm 16/07/2025 (20 minute delay)

SMR (ASX) Chart

Why shareholders should be rejecting the SMR takeover offer, page-7

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Li-S Energy the latest microcap to pivot to US defence market

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why shareholders should be rejecting the SMR takeover offer, page-7

Top Stories

Noxopharm gets HERACLES autoimmune trials started with first human doses

Lumos Diagnostics surges 140% on major US contract deal

Listen: HotCopper Wire Podcast 017 – RBA holds the toppings

Li-S Energy the latest microcap to pivot to US defence market

Wednesday's HotCopper trends: Imugene cap raise, Lumos distribution deal | July 16

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News